Location History:
- La Coruna, ES (1992)
- Santiago de Compostela, ES (1990 - 1995)
Company Filing History:
Years Active: 1990-1995
Title: Ramon Cacabelos: Innovator in Neuropsychiatric Treatments
Introduction
Ramon Cacabelos is a notable inventor based in Santiago de Compostela, Spain. He has made significant contributions to the field of neuropsychiatric disorders through his innovative research and patents. With a total of three patents to his name, Cacabelos has focused on treatments that aim to improve mental function and alleviate symptoms associated with various neuropsychiatric conditions.
Latest Patents
Cacabelos' latest patents include groundbreaking methods for treating neuropsychiatric disorders. One of his notable inventions involves the administration of Somatostatin and growth hormone releasing factor at useful dosage levels. This method has shown promise in alleviating symptoms of various neuropsychiatric disorders. Additionally, his research indicates that growth hormone and neuropsychiatric responses to the administration of growth hormone releasing factor can serve as an antemortem marker for senile dementia of the Alzheimer's type. Another significant patent focuses on the use of growth hormone releasing factor for improving mental function. This method involves administering an effective dosage of Growth Hormone Releasing Factor (GRF) to enhance attention and short-term memory in subjects in need of treatment.
Career Highlights
Throughout his career, Cacabelos has worked with prominent companies such as Laboratorios Serono S.A. and Ares Holding 89 N.V. His experience in these organizations has contributed to his expertise in the field of neuropsychiatry and has facilitated his innovative research.
Collaborations
Cacabelos has collaborated with notable individuals in his field, including Francisco R Vila and Thomas O Alonso. These collaborations have likely enriched his research and contributed to the development of his patents.
Conclusion
Ramon Cacabelos is a distinguished inventor whose work in neuropsychiatric treatments has the potential to make a significant impact on mental health. His innovative patents and collaborations reflect his commitment to advancing the field and improving the lives of those affected by neuropsychiatric disorders.